Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
Chemotherapy is given after curative surgery for pancreas cancer to try to improve cure
rates. There are two choices of chemotherapy which are currently considered equal
treatments: gemcitabine or 5-fluorouracil (5FU). This study is trying to determine if one
of two standard chemotherapies is better than the other depending on whether patients have
high or low human equilibrative nucleoside transporter 1 (hENT1). hENT1 is a protein that
is found in varying amounts on pancreas cancers.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society